Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Regulatory Considerations and Strategies for Drug Repositioning
- 作者Barratt, Michael J.; Frail, Donald E.
- 文件大小174.60KB
- 发表时间2012
- DOI10.1002/9781118274408.ch4
- 页码65-88
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || A Case Study in Drug Repositioning: SoseiBarratt, Michael J.; Frail, Donald E. · 2012
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Systematic Phenotypic Screening for Novel Synergistic Combinations: A New Paradigm for Repositioning Existing DrugsBarratt, Michael J.; Frail, Donald E. · 2012
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || IntroductionBarratt, Michael J.; Frail, Donald E. · 2012
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || IndexBarratt, Michael J.; Frail, Donald E. · 2012
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || FrontmatterBarratt, Michael J.; Frail, Donald E. · 2012
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Drug Repositioning Efforts by Nonprofit FoundationsBarratt, Michael J.; Frail, Donald E. · 2012
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || A Case Study in Drug Repositioning: SoseiBarratt, Michael J.; Frail, Donald E. · 2012
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Business Development Strategies in the Repositioning IndustryBarratt, Michael J.; Frail, Donald E. · 2012
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Regulatory Considerations and Strategies for Drug RepositioningBarratt, Michael J.; Frail, Donald E. · 2012
Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Computational and Bioinformatic Strategies for Drug RepositioningBarratt, Michael J.; Frail, Donald E. · 2012